BTIS
ACAD icon

BB&T Investment Services’s Acadia Pharmaceuticals ACAD Stock Holding History

BB&T Investment Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2K Buy
93
+6
+7% +$192 ﹤0.01% 1226
2017
Q3 		$3K Buy
87
+79
+988% +$2.57K ﹤0.01% 999
2017
Q2 		$0 Hold
8
– – ﹤0.01% 1127
2017
Q1 		$0 Buy
+8
New +$282 ﹤0.01% 1054

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB&T Investment Services's ACAD Position: Q4 2017 in Review

BB&T Investment Services increased its Acadia Pharmaceuticals (ACAD) stake by 6.9% in Q4 2017, buying an estimated $192 and bringing the position to 93 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

BB&T Investment Services first reported a position in ACAD in Q1 2017 and has held it in 4 quarters since. The position peaked at $3K in Q3 2017. 210 funds tracked by Wall St. Rank hold ACAD as of Q4 2017.

  • BB&T Investment Services held 93 shares of Acadia Pharmaceuticals worth $2K as of Q4 2017.
  • BB&T Investment Services bought 6 Acadia Pharmaceuticals shares in Q4 2017, an estimated $192.
  • Acadia Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1226 holding.
  • BB&T Investment Services first reported a position in Acadia Pharmaceuticals in Q1 2017 and has held it in 4 quarters since.
  • BB&T Investment Services's Acadia Pharmaceuticals position peaked at $3K in Q3 2017.
  • 210 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.